Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer's disease.
Alzheimer’s disease (AD)
bioinformatics
biomarker detection
brain diabetes
diabetes mellitus (DM)
genome wide association study
non-coding RNA
type 3 diabetes mellitus
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
05
2022
accepted:
04
08
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
Recent research has investigated the connection between Diabetes Mellitus (DM) and Alzheimer's Disease (AD). Insulin resistance plays a crucial role in this interaction. Studies have focused on dysregulated proteins to disrupt this connection. Non-coding RNAs (ncRNAs), on the other hand, play an important role in the development of many diseases. They encode the majority of the human genome and regulate gene expression through a variety of mechanisms. Consequently, identifying significant ncRNAs and utilizing them as biomarkers could facilitate the early detection of this cross-talk. On the other hand, computational-based methods may help to understand the possible relationships between different molecules and conduct future wet laboratory experiments. In this study, we retrieved Genome-Wide Association Study (GWAS, 2008) results from the United Kingdom Biobank database using the keywords "Alzheimer's" and "Diabetes Mellitus." After excluding low confidence variants, statistical analysis was performed, and adjusted Hsa-miR-199a-5p, hsa-miR-199b-5p, hsa-miR-423-5p, and hsa-miR-3184-5p, the four most significant miRNAs, as well as NEAT1, XIST, and KCNQ1OT1, the three most important lncRNAs, and their interacting proteins in the final tripartite network, have been proposed as new candidate biomarkers in the cross-talk between DM and AD. The literature review also validates the obtained ncRNAs. In addition, miRNA/lncRNA pairs; hsa-miR-124-3p/KCNQ1OT1, hsa-miR-124-3p/NEAT1, and hsa-miR-124-3p/XIST, all expressed in the brain, and their interacting proteins in our final network are suggested for future research investigation. This study identified 127 shared SNPs, 7 proteins, 15 miRNAs, and 11 lncRNAs involved in the cross-talk between DM and AD. Different network analysis and scoring function suggested the most significant miRNAs and lncRNAs as potential candidate biomarkers for wet laboratory experiments. Considering these candidate biomarkers may help in the early detection of DM and AD co-occurrence.
Sections du résumé
Background
UNASSIGNED
Recent research has investigated the connection between Diabetes Mellitus (DM) and Alzheimer's Disease (AD). Insulin resistance plays a crucial role in this interaction. Studies have focused on dysregulated proteins to disrupt this connection. Non-coding RNAs (ncRNAs), on the other hand, play an important role in the development of many diseases. They encode the majority of the human genome and regulate gene expression through a variety of mechanisms. Consequently, identifying significant ncRNAs and utilizing them as biomarkers could facilitate the early detection of this cross-talk. On the other hand, computational-based methods may help to understand the possible relationships between different molecules and conduct future wet laboratory experiments.
Materials and methods
UNASSIGNED
In this study, we retrieved Genome-Wide Association Study (GWAS, 2008) results from the United Kingdom Biobank database using the keywords "Alzheimer's" and "Diabetes Mellitus." After excluding low confidence variants, statistical analysis was performed, and adjusted
Results
UNASSIGNED
Hsa-miR-199a-5p, hsa-miR-199b-5p, hsa-miR-423-5p, and hsa-miR-3184-5p, the four most significant miRNAs, as well as NEAT1, XIST, and KCNQ1OT1, the three most important lncRNAs, and their interacting proteins in the final tripartite network, have been proposed as new candidate biomarkers in the cross-talk between DM and AD. The literature review also validates the obtained ncRNAs. In addition, miRNA/lncRNA pairs; hsa-miR-124-3p/KCNQ1OT1, hsa-miR-124-3p/NEAT1, and hsa-miR-124-3p/XIST, all expressed in the brain, and their interacting proteins in our final network are suggested for future research investigation.
Conclusion
UNASSIGNED
This study identified 127 shared SNPs, 7 proteins, 15 miRNAs, and 11 lncRNAs involved in the cross-talk between DM and AD. Different network analysis and scoring function suggested the most significant miRNAs and lncRNAs as potential candidate biomarkers for wet laboratory experiments. Considering these candidate biomarkers may help in the early detection of DM and AD co-occurrence.
Identifiants
pubmed: 36092798
doi: 10.3389/fnagi.2022.955461
pmc: PMC9451601
doi:
Types de publication
Journal Article
Langues
eng
Pagination
955461Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Ghiam, Eslahchi, Shahpasand, Habibi-Rezaei and Gharaghani.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diabetologia. 2011 Jul;54(7):1684-92
pubmed: 21484216
Neurochem Res. 2018 Aug;43(8):1529-1538
pubmed: 29926354
Aging (Albany NY). 2012 Sep;4(9):590-605
pubmed: 23001356
Diabetes. 2019 May;68(5):988-1001
pubmed: 30833470
Oncotarget. 2017 Oct 4;8(54):93219-93226
pubmed: 29190991
Sci Rep. 2016 May 06;6:25589
pubmed: 27151376
Alzheimers Dement (Amst). 2020 Feb 06;12(1):e12006
pubmed: 32211501
J Cell Physiol. 2019 Jul;234(7):11200-11207
pubmed: 30515796
J Alzheimers Dis. 2017;60(2):721-731
pubmed: 28922161
Front Cell Neurosci. 2020 Feb 19;14:28
pubmed: 32140098
Wiley Interdiscip Rev RNA. 2018 Mar;9(2):
pubmed: 29327503
Nucleic Acids Res. 2015 Jul 1;43(W1):W460-6
pubmed: 25977294
EBioMedicine. 2018 Nov;37:461-470
pubmed: 30314892
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S144-9
pubmed: 26907971
EMBO Mol Med. 2013 Oct;5(10):1613-34
pubmed: 24014289
Clin Interv Aging. 2016 Jun 29;11:867-72
pubmed: 27418812
Front Genet. 2019 Mar 01;10:153
pubmed: 30881384
J Diabetes Res. 2013;2013:452537
pubmed: 23671871
J Clin Med. 2020 Jul 10;9(7):
pubmed: 32664305
Neurobiol Aging. 2019 Dec;84:240.e1-240.e12
pubmed: 30826067
J Psychiatr Res. 2012 Jun;46(6):828-30
pubmed: 22472643
Neurosci Lett. 2009 Oct 23;464(2):140-5
pubmed: 19616072
Neurobiol Aging. 2006 Jul;27(7):918-25
pubmed: 15950321
Int J Mol Sci. 2019 Aug 15;20(16):
pubmed: 31443326
Diabetes Res Clin Pract. 2013 Jan;99(1):1-11
pubmed: 23102915
J Cell Biochem. 2017 Nov;118(11):3855-3865
pubmed: 28387957
Front Genet. 2019 Jan 25;9:703
pubmed: 30740125
Nat Rev Genet. 2008 Jun;9(6):477-85
pubmed: 18427557
Diabetes Metab Syndr Obes. 2020 Feb 13;13:365-375
pubmed: 32104033
Oncotarget. 2017 Mar 7;8(10):16122-16143
pubmed: 28179587
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Arch Neurol. 2008 Jan;65(1):89-93
pubmed: 18195144
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1078-1089
pubmed: 27567931
PLoS One. 2010 Feb 01;5(2):e8898
pubmed: 20126538
Neurosci Biobehav Rev. 2016 May;64:272-87
pubmed: 26969101
Cell Biol Int. 2020 Feb;44(2):630-636
pubmed: 31743528
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Cell Physiol Biochem. 2018;46(2):815-828
pubmed: 29627834
Toxicol Lett. 2012 Feb 25;209(1):94-105
pubmed: 22178568
FEBS Lett. 2018 Sep;592(17):2884-2900
pubmed: 29972883
Mol Med Rep. 2017 Apr;15(4):2143-2153
pubmed: 28260062
Mol Cell Biochem. 2014 Dec;397(1-2):45-51
pubmed: 25084986
Front Neurosci. 2019 Jul 31;13:788
pubmed: 31417349
Hum Genomics. 2018 Aug 23;12(1):41
pubmed: 30139387
Neurobiol Dis. 2014 Dec;72 Pt A:48-53
pubmed: 24907491
Diabetes Metab. 2016 Sep;42(4):263-6
pubmed: 26934823
BMC Immunol. 2021 Jun 16;22(1):37
pubmed: 34134627
J Lipid Res. 2008 Apr;49(4):856-69
pubmed: 18160739
Diabetes. 2002 Apr;51(4):1256-62
pubmed: 11916953
Ageing Res Rev. 2014 Sep;17:43-53
pubmed: 24607832
Sci Rep. 2020 Mar 5;10(1):4107
pubmed: 32139775
Exp Neurol. 2020 Jan;323:113076
pubmed: 31614121
J Parkinsons Dis Alzheimers Dis. 2014 Nov;1(1):
pubmed: 25745640
J Neurol Sci. 2016 Jun 15;365:89-95
pubmed: 27206882
Mol Aspects Med. 2015 Jun-Oct;43-44:66-76
pubmed: 26116273
Int J Mol Sci. 2018 Nov 22;19(12):
pubmed: 30469501
Methods Mol Biol. 2018;1706:91-110
pubmed: 29423795
Genomics Proteomics Bioinformatics. 2012 Oct;10(5):246-53
pubmed: 23200134